BUZZ-AtaiBeckley surges after report says Lilly is nearing buyout deal

AtaiBeckley Inc.
Eli Lilly and Company

AtaiBeckley Inc.

ATAI

0.00

Eli Lilly and Company

LLY

0.00

** Shares of psychedelic drugmaker AtaiBeckley ATAI.O jump 51% to $8.12 in premarket trading

** Bloomberg News reports late on Wednesday pharma giant Eli Lilly LLY.N nears deal to buy co, negotiating at a premium

** ATAI's focus is on psychedelic-based treatments with a nasal spray for treatment-resistant depression under development

** ATAI stands at a market capitalization of $1.97 bln as of last close, per LSEG data

** All 15 brokerages covering ATAI stock rate it "buy" or higher; their median PT is $14 - LSEG data

** Up to last close, the stock is up 31% YTD


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.